0000899243-20-018146.txt : 20200701
0000899243-20-018146.hdr.sgml : 20200701
20200701171503
ACCESSION NUMBER: 0000899243-20-018146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200630
FILED AS OF DATE: 20200701
DATE AS OF CHANGE: 20200701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Misfeldt Dayton
CENTRAL INDEX KEY: 0001461466
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51531
FILM NUMBER: 201006054
MAIL ADDRESS:
STREET 1: C/O BAY CITY CAPITAL LLC
STREET 2: 750 BATTERY STREET, SUITE 400
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001061027
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943295878
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 OYSTER POINT BOULEVARD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-266-3500
MAIL ADDRESS:
STREET 1: 395 OYSTER POINT BOULEVARD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19980709
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-30
0
0001061027
SUNESIS PHARMACEUTICALS INC
SNSS
0001461466
Misfeldt Dayton
SUNESIS PHARMACEUTICALS, INC.
395 OYSTER POINT BOULEVARD, STE. 400
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
See Remarks
Stock Option (Right to Buy)
0.2634
2020-06-30
4
A
0
60000
0.00
A
2030-06-30
Common Stock
60000
60000
D
The option shall vest and become exercisable in twelve (12) equal monthly installments over a one (1) year period following the date of grant subject to the Reporting Person's continuous service on the Board through each such vesting date.
Interim Chief Executive Officer (Principal Executive and Principal Financial Officer).
/s/Dayton Misfeldt
2020-07-01